Climb Bio CLYM
NASDAQ CLYM
$10.19 -0.35 (-3.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Climb Bio (CLYM) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Climb Bio (CLYM) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Climb Bio 776.01 Mn 295.34 Mn - 25.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.60 Mn
Mar 31, 2026 31.90 Mn
Dec 31, 2025 30.53 Mn
Sep 30, 2025 39.08 Mn
Jun 30, 2025 25.48 Mn
Mar 31, 2025 16.00 Mn
Dec 31, 2024 7.00 Mn
Mar 31, 2024 13.75 Mn
Dec 31, 2023 36.75 Mn
Sep 30, 2023 30.50 Mn
Jun 30, 2023 36.93 Mn
Mar 31, 2023 23.25 Mn
Dec 31, 2022 20.99 Mn
Sep 30, 2022 55.25 Mn
Jun 30, 2022 24.61 Mn
Mar 31, 2022 21.55 Mn
API Access

Climb Bio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEY